This curriculum on Comprehensive Approaches to Addressing Atopic Dermatitis in Very Young Patients is designed to equip healthcare professionals with a thorough understanding of effective strategies for managing and treating atopic dermatitis in infants and toddlers. This program integrates the latest medical research and practical insights to ensure participants gain comprehensive knowledge and skills necessary to provide optimal care for this vulnerable patient population.

CME/CE Accreditation Information

This curriculum is designed to empower neurologists and epileptologists with the knowledge to address the unique challenges posed by Developmental and Epileptic Encephalopathies (DEEs). Through a blend of self-study modules, live discussions, and action planning, participants will learn to optimize care for DEE patients by understanding the impact of anti-seizure medications on both seizure and non-seizure symptoms.

CME/CE Accreditation Information

This small group educational experience is designed for clinicians involved in the management of Eosinophilic Esophagitis (EoE). It aims to deepen knowledge of EoE by exploring current treatment modalities, disease characteristics, and therapeutic outcomes. This program will also delve into evolving treatment paradigms and the significance of diagnostic imaging in the context of EoE management.

CME/CE Accreditation Information

This online program on idiopathic hypersomnia provides healthcare professionals with an in-depth understanding of this complex sleep disorder, including its pathophysiology, diagnosis, and management strategies. Through expert-led presentations and case-based discussions, participants will gain practical insights to improve patient outcomes in clinical practice.

CME/CE Accreditation Information

This dynamic course focuses on the exchange of best practices regarding the use of bispecifics in patients with R/R DLBCL including patient eligibility. Through this interactive, small-group activity, participants will review brief modules and patient cases to identify signs and symptoms of toxicities experienced while receiving treatment with bispecific antibodies for R/R DLBCL and also integrate protocols to manage CRS and ICANS effectively when managing patients. The group will gather for a live discussion via Zoom to share and exchange ideas on this topic.

CME/CE Accreditation Information